A Chlamydial Plasmid-Dependent Secretion System for the Delivery of Virulence Factors to the Host Cytosol.


Journal

mBio
ISSN: 2150-7511
Titre abrégé: mBio
Pays: United States
ID NLM: 101519231

Informations de publication

Date de publication:
29 06 2021
Historique:
pubmed: 9 6 2021
medline: 19 11 2021
entrez: 8 6 2021
Statut: ppublish

Résumé

Chlamydia are obligate intracellular Gram-negative bacteria distinguished by a unique developmental biology confined within a parasitophorous vacuole termed an inclusion. The chlamydial plasmid is a central virulence factor in the pathogenesis of infection. Plasmid gene protein 4 (Pgp4) regulates the expression of plasmid gene protein 3 (Pgp3) and chromosomal glycogen synthase (GlgA), virulence factors secreted from the inclusion to the host cytosol by an unknown mechanism. Here, we identified a plasmid-dependent secretion system for the cytosolic delivery of Pgp3 and GlgA. The secretion system consisted of a segregated population of globular structures originating from midcycle reticulate bodies. Globular structures contained the Pgp4-regulated proteins CT143, CT144, and CT050 in addition to Pgp3 and GlgA. Genetic replacement of Pgp4 with Pgp3 or GlgA negated the formation of globular structures, resulting in retention of Pgp3 and GlgA in chlamydial organisms. The generation of globular structures and secretion of virulence factors occurred independently of type 2 and type 3 secretion systems. Globular structures were enriched with lipopolysaccharide but lacked detectable major outer membrane protein and heat shock protein 60, implicating them as outer membrane vesicles. Thus, we have discovered a novel chlamydial plasmid-dependent secretion system that transports virulence factor cargo from the chlamydial inclusion to the host cytosol.

Identifiants

pubmed: 34101486
doi: 10.1128/mBio.01179-21
pmc: PMC8262877
doi:

Substances chimiques

Antigens, Bacterial 0
Bacterial Secretion Systems 0
Virulence Factors 0

Types de publication

Journal Article Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0117921

Références

Mol Microbiol. 2009 Jun;72(6):1423-37
pubmed: 19460098
Microbiology (Reading). 2011 Apr;157(Pt 4):1134-1144
pubmed: 21233161
J Bacteriol. 2013 Sep;195(17):3819-26
pubmed: 23794619
PLoS Negl Trop Dis. 2009 Oct 27;3(10):e460
pubmed: 19859534
Infect Immun. 2017 Dec 19;86(1):
pubmed: 29038127
Microbiol Rev. 1991 Mar;55(1):143-90
pubmed: 2030670
J Bacteriol. 2021 Mar 8;:
pubmed: 33685970
Plasmid. 1986 Jul;16(1):52-62
pubmed: 3016782
Front Microbiol. 2011 Feb 08;2:14
pubmed: 21687409
Infect Immun. 2010 Jun;78(6):2691-9
pubmed: 20351143
Infect Immun. 2015 Dec;83(12):4701-9
pubmed: 26416907
J Bacteriol. 2020 Aug 10;202(17):
pubmed: 32540934
J Bacteriol. 2021 Mar 22;:
pubmed: 33753471
Methods Mol Biol. 2014;1131:47-70
pubmed: 24515459
Infect Immun. 2013 Mar;81(3):636-44
pubmed: 23319558
Nat Rev Microbiol. 2016 Jun;14(6):385-400
pubmed: 27108705
Pathog Dis. 2014 Aug;71(3):336-51
pubmed: 24838663
Infect Immun. 2008 Sep;76(9):3940-50
pubmed: 18591235
PLoS One. 2017 Jun 16;12(6):e0178856
pubmed: 28622339
J Bacteriol. 2011 May;193(10):2498-509
pubmed: 21441519
Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8478-83
pubmed: 12815105
Infect Immun. 2008 Jun;76(6):2273-83
pubmed: 18347045
Microbiology (Reading). 2010 Oct;156(Pt 10):3031-3040
pubmed: 20522495
Infect Immun. 2008 Aug;76(8):3415-28
pubmed: 18474640
Chem Rev. 2011 Oct 12;111(10):6064-119
pubmed: 21936578
Elife. 2016 Mar 16;5:e12552
pubmed: 26981769
J Immunol. 2007 Sep 15;179(6):4027-34
pubmed: 17785841
mBio. 2020 Aug 18;11(4):
pubmed: 32817110
Microb Pathog. 2011 Sep;51(3):101-9
pubmed: 21605656
Infect Immun. 2011 Mar;79(3):1044-56
pubmed: 21199910
PLoS One. 2015 Oct 01;10(10):e0139153
pubmed: 26426122
Nat Rev Microbiol. 2015 Oct;13(10):605-19
pubmed: 26373371
Plasmid. 1990 Mar;23(2):149-54
pubmed: 2194229
PLoS One. 2013 Jul 24;8(7):e68764
pubmed: 23894341
J Exp Med. 2011 Oct 24;208(11):2217-23
pubmed: 21987657
Pathog Dis. 2020 Jun 1;78(4):
pubmed: 32533831
Infect Immun. 2014 Dec;82(12):5327-35
pubmed: 25287930
Microb Cell. 2019 Aug 21;6(9):414-449
pubmed: 31528632

Auteurs

Lei Lei (L)

Chlamydial Diseases Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Chunfu Yang (C)

Chlamydial Diseases Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Michael John Patton (MJ)

Chlamydial Diseases Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Margery Smelkinson (M)

Research Technologies Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

David Dorward (D)

Research Technologies Branch, Rocky Mountain Laboratory, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, USA.

Li Ma (L)

Chlamydial Diseases Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Una Karanovic (U)

Chlamydial Diseases Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Saba Firdous (S)

Chlamydial Diseases Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Grant McClarty (G)

Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Manitoba, Canada.

Harlan D Caldwell (HD)

Chlamydial Diseases Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH